メニュー

Enter a search word

Protein Immuno-engineering against infection outbreaks by variant viruses

【LIFE SCIENCE】 Kuroda Team

  • Overview

    As seen in the recent novel coronavirus epidemic, the ability to rapidly develop vaccines and antivirals is a critical public health issue in a globalized and highly mobile society. In this research unit, biotechnology, bioinformatics, virology, and recombinant genetic engineering is used to develop a technology platform for the rapid development of vaccines and antivirals. In the platform, the physical, biological, and immunological properties of recombinant proteins will be analyzed, and the data and samples will be stored and shared within the research unit. Furthermore, the research objective is to establish basic technologies (vaccine seed molecules, DNA aptamers and compounds for antiviral drugs) to prepare for future viral epidemics.

Team Head

International Researcher(s)

Yves L. Janin

Affiliation Muséum National d'Histoire Naturelle / INSERM / CNRS (France)
Division / Department Organic Chemistry Laboratory
Position Research Director
URL

https://biophysique.mnhn.fr/en/sante-9043

Members

TSUKAKOSHI Kaori  (Institute of Engineering / Assistant Professor)
TAKEMAE Hitoshi  (Center for Infectious Disease Epidemiology and Prevention Research / Associate Professor)
OHBA Mami  (Center for Infectious Disease Epidemiology and Prevention Research / Associate Professor)
VAVRICKA Jr. Christopher John  (Institute of Engineering / Associate Professor)
MIURA Daimei (Institute of Global Innovation Research / Assistant Professor)

このページの上部へ